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Abstract 
OBJECTIVE—It is unclear whether changes in body mass index (BMI) during rapid 
economic development influence subsequent mortality. 
RESEARCH DESIGN AND METHODS— We analyze whether BMI in 1976 and 
1994, and changes in BMI during 1976-1994 predict cardiovascular disease (CVD) 
and all-cause mortality in a 35-year follow-up cohort of 1,696 Chinese (1,124 men 
and 572 women, aged 35-65 years) in Xi'an, China. Participants were categorized as 
underweight (<18.5 kg/m2), normal weight (18.5-24.9 kg/m2), and overweight (≥25.0 
kg/m2). 
RESULTS—During 51,611 person years of follow-up, we identified 655 deaths from 
all-causes and 234 from CVD. From 1976-1994, the prevalence of overweight rose 
from 9.2% to 27.8%. With each unit increment in 1976 BMI, multivariate hazard 
ratios (HRs) (95%CI) were 0.78 (0.72-0.84) for CVD and 0.91(0.87-0.95) for 
all-cause mortality. In contrast, corresponding HRs were 1.14 (1.08-1.19) and 1.05 
(1.01-1.08) in 1994 BMI. The HRs for each unit increment in BMI change from 
1976-1994 were 1.35 (1.25-1.41) for CVD and 1.09 (1.05-1.13) for all-cause. 
Compared to participants with stable normal weight in 1976 and 1994, HRs of 
all-cause mortality for those who had normal weight in 1976 but became overweight 
in 1994 and for those who were persistently overweight during 1976-1994 were 1.42 
(1.12-1.80) and 1.80 (1.04-3.14), respectively. 
CONCLUSIONS—Gaining weight with increased BMI at middle age in Chinese 
during economic development was associated with elevated risks of all-cause and 
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CVD mortality. Higher BMI measured before development was associated with lower 
mortality risk, whereas BMI measured afterwards was associated with increased 
mortality.  
Keywords    body mass index, weight change, mortality, cohort study, Chinese  
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Obesity is a major threat to public health in economically developed countries as 
well as developing nations.1,2 Over the past three decades, China has experienced 
rapid economic development and nutrition transition, and the prevalence of 
overweight and obesity in China has increased 2-3 times since the 1980s.2-4 
 Numerous epidemiological studies and meta-analyses have documented that 
obesity is a strong and independent risk factor for diabetes, cardiovascular disease 
(CVD) and all-cause motality.5,6,7 The association between body mass index (BMI) 
and all-cause mortality showed J-shaped 8,9or U-shaped 10-16 relationships in recent 
studies, including a recently pooled analysis of prospective data from the Asia Cohort 
Consortium7 and five cohort studies from mainland China.12-16 However, nearly all 
previous reports used a single measurement (i.e. baseline), ignoring the changes 
during rapid economic development of these countries. 5-16 Some cohort studies have 
examined the association between weight or BMI change and subsequent 
mortality,17-23 but the duration of follow-up was typically short (<10 years) and 
methodological biases are common, such as confounding by smoking and pre-existing 
diseases.16,20,24  
 In a cohort in Xi’an, China, we measured baseline BMI in 1976 and again in 1994, 
and it provides a unique opportunity to examine BMI before and during economic 
development, and its change in relation to subsequent risk of CVD and all-cause 
mortality. 
 
RESEARCH DESIGN AND METHODS 
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Participants 
Our cohort has been previously described.25 Briefly, from March to May 1976, we 
carried out a cross-sectional survey on risk factors and the prevalence of CVD in a 
machinery factory in Xi'an, a capital city in the central part of China. In total, we 
included 1,696 healthy employees without diagnosed CVD or cancer (1,124 men and 
572 women) in the 1976 baseline cohort. 
 From January to March 1994, we carried out a follow-up survey of the 
participants in the 1976 cohort. Information was collected on the 1,535 surviving 
participants, while 154 participants had died during 1976-94, and 7 participants were 
lost to follow-up. A total of 184 participants (154 deaths, 7 lost to follow-up, and 23  
patients diagnosed with cancer) were excluded from the 1994 dataset and yielded a 
1994 follow-up cohort of 1,512 participants (976 men and 536 women) 
(Supplementary figure 1). 
Data collection 
In 1976 and 1994, trained interviewers conducted face-to-face interviews on 
participants with a standardized questionnaire that included demographic factors 
(education, occupation, and marital status), medical history and family history of 
CVD, and lifestyle factors such as smoking and alcohol consumption. Leisure time 
physical activity was assessed in 1994 only.26 Data were self-reported through 
questions about types of physical activity (e.g., running, tai chi, and playing balls) and 
overall frequency and duration, and was calculated a summary score then divided into 
low, moderate and high levels. 
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 Trained nurses and physicians used a standard protocol for physical examination. 
Height was measured in meters (without shoes). Weight was measured in kilograms, 
without heavy clothing and 1 kg deducted for remaining garments. Fasting plasma 
concentrations of total cholesterol and triglycerides were assessed enzymatically with 
commercially available reagents.  
The Ethics Committees of Chinese PLA General Hospital (EC0411-2001) and 
Faculty of Medicine at University of Hong Kong (EC1246-99) approved the study. 
Exposure and covariables 
Body mass index (BMI, kg/m2) was calculated as weight in kilograms divided by 
the square of height in meters. For a dose-response analysis, BMI (kg/m2) was 
grouped into four categories: <18.5, 18.5–22.9, 23.0-24.9 and ≥25.27 BMI change 
(kg/m2) from 1976-1994 was classified into five categories: <-1.00,±1.00, 1.01–2.00, 
2.01–3.00 and >3.00. Smoking status was categorized into never, current and former 
smokers. Former smokers were defined as those who had quit smoking for at least 
two years and ever-smokers as those who had smoked at least one cigarette daily for 
one year or more. Alcohol consumption was defined as drinking alcohol at least once 
weekly over the past two years. 
Ascertainment of deaths 
Two physicians from the factory hospital tracked and assessed vital status of all 
participants every three years. Payment of pensions and post-death welfare of all 
employees required a report to the personnel department with confirmation by the 
factory hospital; therefore, follow-up of deaths was 100% complete. We used death 
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certificates from hospitals or local police departments to identify causes of death. 
Hospital records of deaths were reviewed by two physicians from the Medical 
University teaching hospital blinded to the exposure status of lifestyle factors of the 
participants, and coded according to ICD-9.  
CVD included Coronary heart disease (CHD) and stroke, and were defined by 
WHO/MONICA criteria.28 Myocardial infarction was diagnosed by a representative 
set of ECG, cardiac enzyme values and typical symptoms. Stroke was defined as 
events requiring hospitalization and over 85% of strokes were confirmed by CT 
and/or MRI. 
Statistical Analysis 
We entered the data (double entry) using Epidata (3.1) and analyzed it with SPSS for 
Windows (20.0). A multivariable Cox proportional hazard regression model was used 
to calculate hazard ratios (HR) with 95% confidence intervals (95% CI) for the 
associations between BMI and risk of CVD and all-cause mortality. The date of death, 
the last date of known survival, or the last date of follow-up for those who were alive 
on that date (July 1, 2011) was used as the right censored date in the proportional 
hazards analysis as appropriate. Seven subjects (6 men and 1 woman) could not be 
traced after they were transferred away from the factory and their last day in the 
factory was considered as the censored date in the analysis of 1976 dataset. Covariates 
included age, marital status, occupation, education, smoking and alcohol drinking, 
change of smoking status in 1994 and physical activity in 1994. 
We tested the interaction between BMI and gender; if not significant, men and 
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women were analyzed together with adjustment for gender. Blood pressure and 
plasma concentrations of triglycerides and total cholesterol were adjusted for 
separately to examine their potential mediation effects, rather than as confounders.29 
Several sensitivity analyses were conducted by excluding deaths occurring in the first 
3 years of follow-up in the 1976 cohort or the 1994 cohort; excluding current smokers 
in 1976 or in 1994 and subjects with COPD diagnosed in 199430; and excluding 
participants whose height declined >3 cm from 1976 to 1994 for considering 
significant decrement in height after the age of 40 in both sexes that could reach a 
2-4cm reduction in height over the life course, particularly in women 31, 32. We also 
examined the relationship of weight change from 1976 to 1994 with subsequent 
mortality. 
 
RESULTS—Of the 1,696 participants, there were 655 total deaths from 15 May 
1976 through 1 July 2011, and 154 deaths in the time period from 1976 to 1994 and 
501 deaths from 1 March 1994 through the end of follow-up. Among the 655 deaths, 
234 (36%) were due to CVD (106 CHD and 128 stroke) and the number of total 
person-years of follow-up (1976-2011) was 51,611, and the mean duration of 
follow-up was 30.4 years. For analyses using 1512 survivors on BMI measured in 
1994 and change of BMI from 1976-94, there were 478 deaths (193 of them were 
CVD) and 22,648 person-years over 14.8 years of follow-up. 
 Table 1 shows the general characteristics of subjects in 1976 and in 1994. In 
1976, the mean (SD) age was 44.4 (6.1) years (range: 35 to 65 years). The 
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demographic characteristics in 1994 were similar at baseline in 1976, although blood 
pressure and lipids significantly increased. From 1976 to 1994, the prevalence of 
overweight (≥25 kg/m2) rose from 7.2% to 25.1% in men and from 13.1% to 32.6% in 
women over the same period.  
 During 1976 to 1994, the mean BMI (95% CI) was changed from 22.1 (22.0-22.2) 
to 23.1 (22.9-23.2) in male, 22.4 (22.2-22.6) to 23.6 (23.4-23.9) in female and 22.2 
(22.1-22.3) to 23.2 (23.1-23.4) in total subjects. The distribution of mean BMI of total 
subjects in 1976 and 1994 is shown in Figure 1. The BMI at 1976 baseline correlated 
with BMI at 1994 follow-up but the correlation was not high (Pearson’s coefficient = 
0.57, P<0.001). 
 Table 2 shows that higher BMI categories (23-24.9 and ≥25 kg/m2) in 1976 were 
associated with significantly lower risk of CVD and all-cause mortality in multivariate 
analyses compared to participants with a BMI of 18.5-22.9 kg/m2. In 1994, however, 
being overweight (BMI>25) was associated with a significantly greater risk of CVD 
mortality (HR=2.15, 95%CI=1.53-3.03) and all-cause (1.27, 1.02-1.59) mortality 
compared to a BMI of 18.5-22.9 kg/m2. Being underweight was associated with 
increased all-cause mortality for 1994 BMI (HR=1.43, 1.00-2.04). 
Table 3 shows that compared to participants with relatively stable BMI (±1.00 
kg/m2), the HRs of CVD mortality across categories of BMI increments (1.00-2.00 
units, 2.01-3.00 units, >3.00 units) were 1.36, 2.65, and 5.69 (p for trend < 0.001), 
respectively. These associations were slightly attenuated after adjustment for blood 
pressure, total cholesterol and triglycerides as intermediates. There was a significant 
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association between an increase ≥3 BMI units from 1976-1994 and all-cause mortality 
(HR=1.80, 1.39-2.34), and it was attenuated to 1.61 (1.23-2.10) after additional 
adjustments.  
 Table 4 shows the HRs of CVD and all-cause mortality according to BMI in 
1976, BMI in 1994, and change in BMI modeled as a continuous variable. Because 
the association of BMI with mortality appeared to be reverse J-shaped in 1976 and 
U-shaped in 1994 (Table 2), participants with BMI <18.5 kg/m2 were excluded from 
the 1976 and 1994 BMI analyses. The multivariate HRs (95% CI) of mortality for 
each one unit increment of BMI in 1976 were 0.78 (0.72-0.84) for CVD and 0.91 
(0.87-0.95) for all-cause mortality. In contrast, the corresponding HRs in 1994 were 
1.14 (1.08-1.20) and 1.05 (1.01-1.08). From 1976 to 1994, each 1 kg/m2 gain in BMI 
was associated with 35% (25%-41%) and 9% (5%-13%) increased risk of CVD and 
all-cause mortality, respectively.  
 Compared to participants who maintained normal weight in both 1976 and 1994, 
those who changed from normal to overweight had highly elevated HRs of CVD (3.39, 
2.38-4.83) and all-cause mortality (1.42, 1.12-1.80) (Figure 2). Those who 
maintained overweight at both time points had the highest risk of CVD (4.02, 
1.49-10.85) and all-cause mortality (1.80, 1.04-3.14). The attributable fraction (AF) 33 
for all-cause mortality in the group of persistent overweight during 1976-1994 and in 
the group with normal weight in 1976 and became overweight was 44.4% 
(3.8%-68.2%) and 29.6% (10.7%-44.4%), respectively.  
  Sensitivity analysis after excluding the deaths during the first 3 years (13 deaths 
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in 1976 cohort and 74 deaths in 1994 cohort) of follow-up did not substantially alter 
the results (Supplementary table 1-2). Similar results were obtained when current 
smokers and subjects with COPD diagnosed in 1994 were excluded from the analyses 
(Supplementary table 3-6). Also, after restricting the analysis to participants whose 
height declined ≤ 3 cm during 1976-1994, the results remained similar 
(Supplementary table 7). Instead of analyzing BMI changes, we also examined the 
relationship between weight change during 1976-1994 and subsequent mortality, and 
the results showed same pattern of BMI changes (Supplementary table 8).  
 
CONCLUSIONS—The follow-up of our cohort spanned more than three decades, 
during a unique period of rapid and unprecedented economic development in China. 
Overall, BMI gain in middle and older aged Chinese was associated with a 
significantly elevated risk of CVD and all-cause mortality. Interestingly, BMI 
measured prior to and during economic development showed opposite associations 
with mortality risk; a higher BMI before development was associated with lower 
mortality risk, whereas an elevated BMI in the midst of economic development was 
associated with increased mortality. These findings provide first prospective evidence 
on the association of BMI at two times (before and during industrialization) and 
changes in BMI between these two times and subsequent risk of CVD and total 
mortality in China and developing countries. 
 Most evidence on the relationship between BMI and weight change and 
subsequent mortality was derived from Western nations17,18,20,21,34 or developed Asian 
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countries (e.g., Japan) where their baseline data were collected after economic 
development.20,23 Thus, these findings may not apply to developing countries, such as 
China. Moreover, results from previous studies have been inconsistent 17-24, 34-36 and 
these discrepancies may be due to different degrees of reverse causation (weight loss 
due to pre-existing chronic diseases) or or obesity paradox 30, varied economic and 
social developments in different populations 19, 20 and other methodological 
issues.3,17-24 
 China’s economic reform began in 1978. Since then, in parallel with a rapid 
economic development and a nutrition transition, the prevalence of overweight and 
obesity has increased substantially.37 Three nationally-representative surveys 
conducted in 1981, 1992 and 1998 among middle-aged men and women showed that 
the prevalence of overweight (by WHO criteria of BMI≥25 kg/m2) increased 
significantly from the early 1980s (9.9% in men and 14.6% in women) to the early 
1990s (19.6% in men and 26.1% in women), and the late 1990’s (23.5% for men and 
28.5% for women).3 In our cohort, the prevalence of overweight increased from 9.2% 
to 27.8% between 1976 and 1994, which is broadly consistent with the national trend 
from multiple cross-sectional surveys,3,4 although the age distribution in our cohort 
changed over time. 
 Anthropometric measurements, such as BMI, are useful markers of the nutritional 
status for individuals and populations. In Western populations, obesity is typically 
correlated with lower educational levels and low socioeconomic status.37,38 In contrast, 
in less developed countries, low BMI is considered as a marker of under-nutrition, and 
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low socio-economical status (SES),38,39 while a higher BMI tends to be associated 
with higher SES and better nutritional status. This was especially true in less 
developed countries like China and India prior to the onset of economic 
development,37 and this may explain the inverse association between BMI measured 
in 1976 and mortality risk observed in our cohort, and from a study conducted in rural 
India.19 Other studies from Asia also found a positive association between higher BMI 
and education, better living standards, and an inverse association with mortality.37,40  
 Five prospective studies conducted in mainland China, three based on BMI 
measured in the 1980s 12-14 and two in 1991,15,16 showed that both underweight and 
obesity were associated with increased mortality in the Chinese adult population. 
These results were similar to our findings based on BMI measured in 1994. The 
positive association between BMI and mortality in 1994 may reflect two observations. 
First, the prevalence of overweight and obesity had become more common in 1994, 
which increased our power to observe the association.2-4,37 Second, higher BMI in 
1994 was probably more likely to reflect increased adiposity and its detrimental 
effects of body fatness on health outcomes.  
In the present study, a gain of 1 kg/m2 BMI from 1976 to 1994 was associated 
with a 35% increased risk for CVD and a 9% greater risk for all-cause mortality. 
These associations were stronger than those observed by analysing 1994 BMI data 
alone. Few studies have examined the association of BMI or weight change assessed 
in middle age with mortality risk. Several studies in the US and Europe showed that 
weight loss, but not weight gain, was associated with increased mortality from 
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all-causes and CVD.21,22 These paradoxical findings known as the “obesity paradox” 
was increasing in some studies and shown that those patients, especially elderly, with 
several chronic diseases (CHD, chronic heart failure, peripheral arterial disease, stroke, 
COPD, type 2 diabetes, etc) and elevated BMI may demonstrate lower all-cause and 
cardiovascular mortality compared with patients of normal weight.30 Two Japanese 
studies showed that a large weight change, either loss or gain, was associated with an 
increased risk of mortality.20, 23  
Using stable and normal weight participants as the reference group, for all-cause 
mortality, we estimated an attributable fraction of 44% in the participants who were 
persistently overweight during 1976-94 and of 29.6% in normal weight participants in 
1976 who had become overweight in 1994. These estimates could be translated into 
alarming public health messages, suggesting that if the relationships are causal, about 
half of those who were overweight during the entire follow-up would be killed 
prematurely by their persistent overweight (from diseases associated with or induced 
by persistent overweight) and one-third of the people who became overweight during 
18 years of rapid economic development in China would be killed by diseases 
associated with weight gain. 
Our findings should have global public health implications. Many developing 
countries undergoing economic development and nutrition transition carry a dual 
burden of disease with the coexistence of under and over nutrition.35 The transition 
from under-nutrition to over-nutrition heralds an impending epidemic of 
obesity-related chronic diseases (such as CVD) and health outcomes, especially 
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mortality.41 Our findings may help explain the inconsistent relationships between BMI 
and mortality observed in different populations at various stages of economical 
development and nutrition transitions. A recent meta-analysis showed a reduced 
mortality in overweight and moderately obese group, but the results have been highly 
controversial. Some of the studies included in the meta-analysis were based on Asian 
populations but none considered different stage of economic developments.6 Clearly, 
more long-term studies with regular and multiple repeated measures of BMI and other 
indicators of obesity (such as waist circumference and waist to hip ratio) are needed to 
monitor changes in obesity status during the course of nutrition transitions in 
developing countries and their consequences on morbidity and mortality. 
To our knowledge, this is the first and longest-running cohort study in China. Our 
follow-up rate was extremely high over 35 years, with only 0.4% of participants lost 
to follow-up. This study is unique in that two repeated measurements of BMI, an 
occupational cohort with related stable social characteristics before and during 
economic development, allowed us to examine the relationship between changes in 
BMI and subsequent mortality. Moreover, we adjusted for important confounding 
variables such as education, occupation, physical activity, alcohol drinking and 
change in smoking status. To minimize reverse causation or obesity paradox due to 
underlying diseases (such as COPD) and smoking, sensitivity analyses were also 
carried out and showed similar results.  
This study has some limitations. First, we did not collect data on dietary factors; 
such information may have helped us better understand the role of nutrition transition 
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on changes in BMI during follow-up. Second, because our sample was derived from 
survivors of a cohort recruited 18 years earlier, some bias in estimating the 
relationship between 1994 BMI and subsequent mortality might have been introduced. 
However, the number of deaths that occurred between 1976 and 1994 was small 
(n=154). Third, our sample size was relatively small and thus we were not able to 
conduct subgroup analysis by age or other covariates. However, we had sufficient 
power to detect the associations between BMI as well as BMI change and mortality 
risk, partly due to the long duration of follow-up and nearly 100% follow-up rate.  
Finally, because all participants were Chinese, it is unclear whether the results can be 
generalized to other ethnic groups. 
In summary, this long-term prospective study demonstrated that gaining weight 
with increased BMI at middle-aged and older Chinese during economic development 
was associated with an elevated risk of all-cause and CVD mortality. A higher BMI 
measured before economic development was associated with lower mortality risk, 
whereas higher BMI measured afterwards was associated with increased mortality. 
This study underscores the importance of preventing overweight and obesity in 
countries undergoing economic development.  
(Word count: 3, 030) 
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